Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis
- First Posted Date
- 2013-01-02
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- Biocad
- Target Recruit Count
- 181
- Registration Number
- NCT01759030
- Locations
- 🇺🇦
National Research Center "Cardiology Institute n.a. M.D.Strazheska", Kyiv, Ukraine
🇮🇳Jaipur Hospital, Lal Kothi, Near SMS Stadium, Jaipur, India
🇮🇳Smt NHL Medical College and SethVS General Hospital, Ahmadabad, India
Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-12-04
- Last Posted Date
- 2015-08-18
- Lead Sponsor
- Biocad
- Target Recruit Count
- 150
- Registration Number
- NCT01740089
- Locations
- 🇷🇺
Moscow State University of Medicine and Dentistry, Moscow, Russian Federation
Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Biocad
- Target Recruit Count
- 174
- Registration Number
- NCT01701232
- Locations
- 🇮🇳
HCG Bangalore Institute of Oncology, Bangalore, India
🇮🇳Acharya Tulasi Regional Cancer Treatment and Research Centre, Bikaner, India
🇮🇳Department of Medical Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, India
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-02
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- Biocad
- Target Recruit Count
- 60
- Registration Number
- NCT01569087
- Locations
- 🇷🇺
Arkhangelsk District Clinical Oncology Dispensary, Arkhangelsk, Russian Federation
🇷🇺Perm Region Oncology Dispensary, Perm, Russian Federation
🇷🇺N.N.Petrov Oncology Research Center, St.Petersburg, Russian Federation
© Copyright 2024. All Rights Reserved by MedPath